Rheumatic Immune-Related Adverse Events: Immune Checkpoint Inhibitor Therapy and Ramifications for Health Disparities
The significantly lower rate of referrals to rheumatologists among patients with rheumatic irAEs at a public MC compared to patients at a neighboring private MC raises concern for healthcare disparities. Larger studies with racially diverse patients are necessary to help ensure equitable care for all patients.
Authors
- William Stohl (ORCID: https://orcid.org/0000-0002-8272-7873)
- Kathryn J. Ruddy (ORCID: https://orcid.org/0000-0001-6298-332X)
- Nicole K. Zagelbaum (ORCID: https://orcid.org/0000-0002-1304-0242)
- Laura C Kobashigawa
- Baljeet Rai (ORCID: https://orcid.org/0000-0002-4098-7992)
- Micaela Delgado
- Elizabeth Taylor‐Albert
- Victoria Gevorgyan (ORCID: https://orcid.org/0000-0003-0883-7684)
- Kiana Mortezaei
Institutions
- University of Southern California (US)
Publication Details
- Journal
- Cureus
- Published
- 2025-08-20
- DOI
- https://doi.org/10.7759/cureus.90585
- Citations
- 1
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.63